Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass

Detalles Bibliográficos
Autores principales: Radovits, Tamás, Korkmaz, Sevil, Loganathan, Sivakkanan, Stasch, Johannes-Peter, Karck, Matthias, Szabó, Gábor
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Poster Presentation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313370/
http://dx.doi.org/10.1186/1471-2210-9-S1-P56
_version_ 1782227982653325312
author Radovits, Tamás
Korkmaz, Sevil
Loganathan, Sivakkanan
Stasch, Johannes-Peter
Karck, Matthias
Szabó, Gábor
author_facet Radovits, Tamás
Korkmaz, Sevil
Loganathan, Sivakkanan
Stasch, Johannes-Peter
Karck, Matthias
Szabó, Gábor
author_sort Radovits, Tamás
collection PubMed
description
format Online
Article
Text
id pubmed-3313370
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-33133702012-03-28 Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass Radovits, Tamás Korkmaz, Sevil Loganathan, Sivakkanan Stasch, Johannes-Peter Karck, Matthias Szabó, Gábor BMC Pharmacol Poster Presentation BioMed Central 2009-08-11 /pmc/articles/PMC3313370/ http://dx.doi.org/10.1186/1471-2210-9-S1-P56 Text en Copyright ©2009 Radovits et al; licensee BioMed Central Ltd.
spellingShingle Poster Presentation
Radovits, Tamás
Korkmaz, Sevil
Loganathan, Sivakkanan
Stasch, Johannes-Peter
Karck, Matthias
Szabó, Gábor
Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass
title Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass
title_full Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass
title_fullStr Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass
title_full_unstemmed Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass
title_short Pharmacological preconditioning with the guanylate cyclase activator cinaciguat (BAY 58-2667) protects against reperfusion injury after cardiopulmonary bypass
title_sort pharmacological preconditioning with the guanylate cyclase activator cinaciguat (bay 58-2667) protects against reperfusion injury after cardiopulmonary bypass
topic Poster Presentation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3313370/
http://dx.doi.org/10.1186/1471-2210-9-S1-P56
work_keys_str_mv AT radovitstamas pharmacologicalpreconditioningwiththeguanylatecyclaseactivatorcinaciguatbay582667protectsagainstreperfusioninjuryaftercardiopulmonarybypass
AT korkmazsevil pharmacologicalpreconditioningwiththeguanylatecyclaseactivatorcinaciguatbay582667protectsagainstreperfusioninjuryaftercardiopulmonarybypass
AT loganathansivakkanan pharmacologicalpreconditioningwiththeguanylatecyclaseactivatorcinaciguatbay582667protectsagainstreperfusioninjuryaftercardiopulmonarybypass
AT staschjohannespeter pharmacologicalpreconditioningwiththeguanylatecyclaseactivatorcinaciguatbay582667protectsagainstreperfusioninjuryaftercardiopulmonarybypass
AT karckmatthias pharmacologicalpreconditioningwiththeguanylatecyclaseactivatorcinaciguatbay582667protectsagainstreperfusioninjuryaftercardiopulmonarybypass
AT szabogabor pharmacologicalpreconditioningwiththeguanylatecyclaseactivatorcinaciguatbay582667protectsagainstreperfusioninjuryaftercardiopulmonarybypass

Ejemplares similares